Ramen Ventures

Ramen Ventures, founded in 2016 and based in Toronto, Canada, is an angel investment group dedicated to helping startups progress from the prototype stage to achieving ramen profitability. The firm focuses on a diverse range of sectors, including aerospace, biotechnology, clean technology, financial technology, health, software as a service (SaaS), artificial intelligence, augmented reality, and virtual reality. By providing strategic support and funding, Ramen Ventures aims to foster innovation and growth in these emerging industries.

Adam McNamara

Managing Partner and Co-Founder

Joshua Tessier

Partner and Co-Founder

21 past transactions

Mayday

Seed Round in 2022
Mayday Labs Inc. is a Toronto-based company that specializes in designing and developing wellness and productivity software solutions. Founded in 2018, the company focuses on creating an AI-assisted scheduling tool that helps users organize and optimize their time effectively. This tool analyzes how time is allocated across various activities and offers calendar management features, including automatic travel time scheduling. By providing personalized assistance and recommendations for daily time management, Mayday Labs aims to enhance productivity and adapt to changing schedules, enabling users to manage their time more efficiently.

Spare

Series A in 2021
Spare is a mobility management software company that enhances public transit services through on-demand and shared transportation solutions. The platform integrates various modes of transport, enabling efficient and accessible mobility for all users. Their platform uses advanced algorithms and data analytics to optimize routes, reduce wait times, and improve overall efficiency for transportation services. By optimizing transportation services and promoting shared rides, Spare Labs reduces traffic congestion and emissions, supporting more sustainable urban mobility.

ALT TEX

Pre Seed Round in 2021
ALT TEX is a biotechnology company focused on producing carbon-neutral fabric from post-industrial waste and landfill-destined food waste. By chemically regenerating food waste into a bioplastic, ALT TEX offers a sustainable alternative to conventional polyester, which is commonly used in the fashion industry. This innovative approach not only reduces reliance on synthetic textiles but also contributes to environmental sustainability by diverting waste from landfills. The company's bioplastic fibers can be utilized in the creation of various textiles, aligning with the growing demand for eco-friendly materials in fashion and textiles.

Eli

Seed Round in 2020
Eli is a company focused on empowering women to manage their health by providing insights into their hormone profiles. It has developed an at-home device that monitors hormones using saliva samples, allowing for daily tracking of hormonal changes. Alongside the device, Eli offers an app that delivers personalized insights based on the collected data. The primary aim of Eli is to offer women a reliable and effective means to take charge of their fertility and contraception choices, thereby enhancing their overall health and well-being.

Planetary

Angel Round in 2020
Planetary Hydrogen is a company focused on producing clean hydrogen while capturing atmospheric carbon through innovative ocean alkalinity enhancement. The company develops advanced ocean-based carbon removal technologies designed to accelerate the natural carbon cycle. Its system works by purifying alkaline rock waste resulting from large-scale mining operations, extracting alkalinity, and introducing it into the ocean. This process aims to rebalance ocean chemistry and facilitate the carbon transition. Planetary Hydrogen is committed to removing one billion tonnes of carbon dioxide from the atmosphere by 2035, contributing to global efforts in combating climate change.

Membio

Seed Round in 2020
Membio's single-use 0.2-10 L benchtop bioreactor system uses a proprietary design to provide a constant environment for cells at all scales. One technique will provide the same outcomes at all scales, whether at 0.2 L, 10 L, or anywhere in between. Fully automated single-use bioreactors designed by the business to enable cost-effective and scalable manufacture.

Ada

Series B in 2020
Ada Support Inc. is a Toronto-based company that specializes in developing a chatbot platform designed to enhance customer experience for enterprise businesses. Founded in 2016, the platform utilizes artificial intelligence and machine learning to automate customer support processes. By enabling non-technical support teams to manage inquiries effectively, Ada's technology reduces overall support volume and allows customers to find answers independently. The system continuously learns from interactions, improving its ability to serve customers over time.

Lobo Genetics

Venture Round in 2020
Lobo Genetics is a healthcare technology company focused on enhancing understanding of individual responses to cannabis through genetic analysis. The company offers a direct-to-consumer platform that provides personalized insights into how individuals may react to various compounds found in cannabis and psychedelics. By utilizing DNA testing, Lobo Genetics delivers actionable insights within an hour, allowing patients to make informed decisions about safe cannabis use based on their genetic profiles.

Mayday

Pre Seed Round in 2019
Mayday Labs Inc. is a Toronto-based company that specializes in designing and developing wellness and productivity software solutions. Founded in 2018, the company focuses on creating an AI-assisted scheduling tool that helps users organize and optimize their time effectively. This tool analyzes how time is allocated across various activities and offers calendar management features, including automatic travel time scheduling. By providing personalized assistance and recommendations for daily time management, Mayday Labs aims to enhance productivity and adapt to changing schedules, enabling users to manage their time more efficiently.

ClaimCompass

Seed Round in 2019
ClaimCompass, Inc. is a legal services company based in Mountain View, California, founded in 2015. It operates an online platform that assists airline passengers in obtaining compensation for various travel disruptions, including delayed, canceled, or overbooked flights. The platform specifically processes claims for flights departing from airports within the European Union, allowing passengers to claim compensation of up to six hundred euros. By streamlining the claims process, ClaimCompass aims to ensure that passengers receive the compensation they are entitled to for their travel inconveniences.

Lilia

Pre Seed Round in 2019
Lilia is a fertility support company that offers comprehensive services to women, focusing on egg freezing and family planning. Founded in 2019, Lilia provides a home-based diagnostic test for fertility hormone assessment and operates a resource hub that connects prospective parents with fertility specialists. The company's concierge service assists individuals in navigating their fertility options, providing well-researched data related to egg count, menopause timing, and age to inform decisions. By offering low-cost fertility management services, Lilia aims to empower busy individuals who wish to preserve their options for parenthood later in life. Headquartered in Toronto, Canada, Lilia serves clients primarily in San Francisco, California.

Qurcan Therapeutics

Seed Round in 2019
Qurcan Therapeutics is focused on developing advanced therapeutic solutions for solid tumors, particularly brain cancers. The company has created a nanotechnology-based drug delivery platform that enhances the precision of cancer treatment by overcoming challenges associated with traditional drug delivery methods. This platform improves the release of therapeutic agents while minimizing liver accumulation, allowing for more effective targeting of difficult-to-reach tumors. Among its innovations is Manganescan®, a theranostic agent that serves as both an MRI contrast agent and a radio-sensitizer, enabling early detection of brain tumors and enhancing the effectiveness of radiation therapy. By facilitating improved drug delivery and modulating the tumor microenvironment, Qurcan Therapeutics aims to increase therapeutic efficacy and extend patient survival in the fight against solid tumor cancers.

Vital Bio

Seed Round in 2019
Vital Bio is focused on transforming lab testing to make healthcare more accessible and personalized. The company develops advanced diagnostic technologies that connect diagnosis and treatment through a comprehensive ecosystem of devices, software, and services. By empowering patients to monitor their health and manage diseases, Vital Bio aims to enhance the overall healthcare experience. Their approach seeks to reduce disparities in healthcare outcomes and redistribute control to patients while equipping healthcare providers with the tools necessary to achieve better results.

Bright Breaks

Pre Seed Round in 2019
Bright Breaks offers a workplace wellness solution to boost employee wellness, connection, and productivity with 7-minute live micro-breaks. Bright Breaks' wellness platform is designed to provide users with maximum benefits while requiring the least amount of effort. It only takes a few minutes per day to reduce stress and improve well-being.

Kora

Pre Seed Round in 2019
Kora is a pan-African payment infrastructure company headquartered in Canada, with additional offices in Nigeria and the United Kingdom. The company specializes in facilitating pay-ins and payouts for local and global businesses across various payment channels in Africa. Kora's platform utilizes blockchain technology to provide an efficient cross-border payments solution, which aims to reduce the costs associated with remittances. By enabling individuals and businesses to receive payments from anywhere in the world, Kora contributes to enhancing the accessibility and affordability of financial transactions across the continent.

ProteinQure

Pre Seed Round in 2018
ProteinQure Inc. is a biotechnology company based in Toronto, Canada, founded in 2017. It specializes in the development and manufacturing of protein-based therapeutic drugs, focusing on the design of novel exotic peptides for a wide range of therapeutic applications. The company employs advanced technologies such as quantum computing, molecular simulations, and reinforcement learning to facilitate the engineering of novel therapeutics. By utilizing atomic-level simulations and artificial intelligence, ProteinQure aims to create dynamic peptides that effectively target specific disease pathways, potentially outperforming traditional drug delivery systems. The company’s innovative approach seeks to enhance drug discovery and design, offering new possibilities for treating previously untreatable conditions. ProteinQure prides itself on its diverse team, which integrates expertise from experimental and computational biology, machine learning, and software engineering to advance the field of drug development.

Phenomic AI

Seed Round in 2018
Phenomic AI Inc. is a biotechnology company based in Toronto, Canada, founded in 2017. The company specializes in developing artificial intelligence solutions to enhance drug discovery and the creation of therapies for cancer. Its innovative platform utilizes AI, computer vision, and high-content screening to analyze phenotypes in complex disease models, such as high-content co-culture and three-dimensional assays. By focusing on the tumor stroma, Phenomic AI aims to optimize the discovery and development of new medicines, streamlining the process for pharmaceutical companies to identify potential drug candidates more effectively.

Avro

Seed Round in 2018
Avro Life Science is a Canadian company focused on developing transdermal drug delivery systems, specifically medicated skin patches designed for the pediatric and elderly populations. Utilizing a novel biopolymer as a platform, Avro's technology enables passive delivery of small molecules and drugs directly into the bloodstream, allowing for a slow-release mechanism. This innovative approach aims to enhance medication accessibility while minimizing the impact on the liver, ultimately improving health outcomes and quality of life for its patients.

Welbi

Angel Round in 2018
Welbi is a company focused on enhancing the quality of life for older adults in senior living communities by optimizing care delivery. Its platform simplifies administrative tasks, allowing staff to dedicate more time to engaging residents and fostering meaningful connections. By offering personalized programming and real-time insights, Welbi equips senior living communities with the tools necessary to understand and respond to the evolving needs of their residents. This approach aims to prevent social isolation among older adults and enrich their overall experience within these communities.

Hypercare

Angel Round in 2018
Hypercare operates a healthcare coordination platform designed to enhance clinical communication and collaboration among providers. This platform addresses the growing complexity of patient care, which often requires input from multiple providers across various departments and specialties. Traditional communication methods in hospitals, such as switchboards and pagers, have proven ineffective, resulting in delays in patient care and suboptimal outcomes. Hypercare's solution facilitates secure and efficient communication among healthcare professionals in diverse settings, including hospitals, long-term care facilities, and community care organizations. By enabling providers to connect quickly and effectively, Hypercare aims to minimize interruptions and improve patient-centered care while ensuring the protection of personal health information.

Spartan Bioscience

Angel Round in 2016
Spartan Bioscience Inc. specializes in the design and manufacture of rapid sample-to-result DNA testing systems. Founded in 2005 and based in Ottawa, Canada, the company offers a fully integrated technology that combines DNA collection, extraction, and analysis, all presented through an intuitive interface for ease of use. One of its notable products is the CYP2C19 system, which assists clinicians in determining therapeutic strategies for patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.